All Stories

  1. Do patients trust the FDA?: a survey assessing how patients view the generic drug approval process

    Article • Pharmacoepidemiology and Drug Safety, March 2017, Wiley

    Dr Aaron Kesselheim, Jessica Franklin

  2. Mandatory Disclaimers On Dietary Supplements Do Not Reliably Communicate The Intended Issues

    Article • Health Affairs, March 2015, Health Affairs

    Dr Aaron Kesselheim

  3. The Roles Of Academia, Rare Diseases, And Repurposing In The Development Of The Most Transformative Drugs

    Article • Health Affairs, February 2015, Health Affairs

    Dr Aaron Kesselheim

  4. Existing FDA Pathways Have Potential To Ensure Early Access To, And Appropriate Use Of, Specialty Drugs

    Article • Health Affairs, October 2014, Health Affairs

    Dr Aaron Kesselheim

  5. Restrictions On Pharmaceutical Detailing Reduced Off-Label Prescribing Of Antidepressants And Antipsychotics In Children

    Article • Health Affairs, June 2014, Health Affairs

    Dr Aaron Kesselheim

  6. Quantifying The Food And Drug Administration's Rulemaking Delays Highlights The Need For Transparency

    Article • Health Affairs, February 2014, Health Affairs

    Dr Aaron Kesselheim, Daniel Carpenter

  7. Secondary Patenting Of Branded Pharmaceuticals: A Case Study Of How Patents On Two HIV Drugs Could Be Extended For Decades

    Article • Health Affairs, October 2012, Health Affairs

    Dr Aaron Kesselheim

  8. The Food And Drug Administration Has The Legal Basis To Restrict Promotion Of Flawed Comparative Effectiveness Research

    Article • Health Affairs, October 2012, Health Affairs

    Dr Aaron Kesselheim

  9. Clinical Decision Support Systems Could Be Modified To Reduce 'Alert Fatigue' While Still Minimizing The Risk Of Litigation

    Article • Health Affairs, December 2011, Health Affairs

    Dr Aaron Kesselheim, Dr David W. Bates, Professor Aziz Sheikh

  10. False Claims Act Prosecution Did Not Deter Off-Label Drug Use In The Case Of Neurontin

    Article • Health Affairs, December 2011, Health Affairs

    Dr Aaron Kesselheim